Join over 2,000+ Investors
Register now and embark on your journey to informed and successful investing.
LFCR | US
-0.04
-0.99%
Healthcare
Drug Manufacturers-Specialty & Generic
31/08/2024
20/03/2026
4.02
3.98
4.05
3.90
Lifecore Biomedical Inc. together with its subsidiaries operates as an integrated contract development and manufacturing organization in the United States and internationally. The company operates through Lifecore Curation Foods and Other segments. The Lifecore segment engages in the manufacture of pharmaceutical-grade sodium hyaluronate (HA) in bulk form as well as formulated and filled syringes and vials for injectable products used in treating a range of medical conditions and procedures. It also provides services including technology development material component changes analytical method development formulation development pilot studies stability studies process validation and production of materials for clinical studies to its partners for HA-based and non-HA based aseptically formulated and filled products. This segment sells its non-HA products for medical use primarily in the ophthalmic orthopedic and other markets. The Curation Foods segment engages in processing marketing and selling of olive oils and wine vinegars under the O brand; and guacamole and avocado food products under the Yucatan and Cabo Fresh brands as well as various private labels. The company was formerly known as Landec Corporation and changed its name to Lifecore Biomedical Inc. in November 2022. Lifecore Biomedical Inc. was incorporated in 1986 and is based in Chaska Minnesota.
View LessLow Debt to Equity (< 0.25)
Negative Momentum (Declining Price)
Weakness based on declining price with high volume
Price Below SMA10D
High Short-term Volatility
High Current Volume and Negative 1-Day Return
Microcap (<300M USD)
Weak P/E, and PEG ratio indicator
High Market Beta (> 0.8)
High Short percentage (> 15%)
Rich in Valuation (Price to Book > 8)
Weak Operating Margin (< 10%)
Weak Sharpe Ratio (< 0.3)
Bullish: Stable Volatility (6-month <= 1-month volatility) is positive for the stock performance.
10 days
153.6%1 month
110.7%3 months
74.5%6 months
63.0%40.08
8.67
15.35
-32.48
0.52
9.51
2.52
3.51
-674.00K
148.04M
148.04M
-
-36.77
-
0.70
17.29
11.12
16.67
Short-term: Bearish (SMA10D < SMA1M)
Intermediate-term: Bearish (SMA1M < SMA3M)
Long-term: Bullish (SMA6M > SMA12M)
Range10D
3.27
Range1M
3.58
Range3M
5.08
Rel. volume
2.32
Price X volume
3.19M
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| Alpha Teknova Inc. Common Stock | TKNO | Drug Manufacturers-Specialty & Generic | 2.79 | 148.72M | -2.11% | n/a | 39.24% |
| Heron Therapeutics Inc | HRTX | Drug Manufacturers-Specialty & Generic | 0.7786 | 118.09M | -4.74% | n/a | -471.04% |
| Canopy Growth Corporation | CGC | Drug Manufacturers-Specialty & Generic | 0.9448 | 104.71M | -6.46% | n/a | 117.00% |
| CRDL | CRDL | Drug Manufacturers-Specialty & Generic | 0.926 | 73.72M | -2.22% | n/a | 1.07% |
| Cannex Capital Holdings Inc | ARRXF | Drug Manufacturers-Specialty & Generic | 0.2694 | 68.66M | 22.45% | n/a | 0.50% |
| Universe Pharmaceuticals INC | UPC | Drug Manufacturers-Specialty & Generic | 2.4 | 56.75M | -2.52% | n/a | 24.34% |
| Cumberland Pharmaceuticals Inc | CPIX | Drug Manufacturers-Specialty & Generic | 2.83 | 39.89M | -1.74% | n/a | 81.86% |
| Lipocine Inc | LPCN | Drug Manufacturers-Specialty & Generic | 7.15 | 38.24M | -2.19% | n/a | 0.00% |
| INC Research Holdings Inc | INCR | Drug Manufacturers-Specialty & Generic | 0.7737 | 35.41M | 0.49% | n/a | 28.90% |
| SCYNEXIS Inc | SCYX | Drug Manufacturers-Specialty & Generic | 0.9323 | 35.29M | 4.28% | n/a | 25.73% |
Name | Ticker | Industry | Close | Marketcap | Day Return | PE Ratio | Debt to Equity |
|---|---|---|---|---|---|---|---|
| CPI Card Group Inc | PMTS | Building Products & Equipment | 13.18 | 147.06M | -5.59% | 15.61 | -621.78% |
| ONEWATER MARINE INC. | ONEW | Recreational Vehicles | 8.65 | 138.89M | 3.10% | n/a | 286.96% |
| Kewaunee Scientific Corporation | KEQU | Building Products & Equipment | 34.1 | 97.93M | -0.15% | 5.16 | 19.82% |
| Virco Mfg. Corporation | VIRC | Building Products & Equipment | 5.91 | 96.27M | 0.08% | 9.09 | 39.79% |
| Unifi Inc | UFI | Textile Manufacturing | 3.65 | 66.63M | 1.39% | n/a | 52.56% |
| ILAG | ILAG | Building Products & Equipment | 2.35 | 42.44M | 8.90% | n/a | 5.48% |
| Culp Inc | CULP | Textile Manufacturing | 2.79 | 34.85M | -6.06% | n/a | 11.29% |
| Antelope Enterprise Holdings Limited | AEHL | Building Products & Equipment | 1.58 | 23.09M | -4.82% | 0.03 | 16.03% |
| REE Automotive Ltd. Class A Ordinary Shares | REE | Recreational Vehicles | 0.5225 | 10.10M | -5.34% | n/a | 58.43% |
| The Dixie Group Inc | DXYN | Textile Manufacturing | 0.4336 | 6.67M | n/a | 422.08% |
| Parameter | Company | Industry | Indicator |
|---|---|---|---|
| Enterprise to EBITDA | 9.51 | - | Cheaper |
| Ent. to Revenue | 2.52 | - | Cheaper |
| PE Ratio | 40.08 | 30.05 | Expensive |
| Price to Book | 15.35 | 13.15 | Par |
| Dividend Yield | - | - | - |
| Std. Deviation (3M) | 74.47 | - | Par |
| Debt to Equity | -32.48 | -1.88 | Cheaper |
| Debt to Assets | 0.52 | 0.48 | Par |
| Market Cap | 148.04M | - | Emerging |